STERIS plc (NYSE:STE) SVP Cary L. Majors Sells 2,024 Shares

STERIS plc (NYSE:STE - Get Free Report) SVP Cary L. Majors sold 2,024 shares of the business's stock in a transaction that occurred on Monday, May 13th. The shares were sold at an average price of $232.13, for a total transaction of $469,831.12. Following the sale, the senior vice president now owns 11,369 shares in the company, valued at approximately $2,639,085.97. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

STERIS Stock Performance

STE traded down $0.54 on Wednesday, hitting $235.46. The company had a trading volume of 690,052 shares, compared to its average volume of 486,301. The stock has a market cap of $23.27 billion, a price-to-earnings ratio of 61.64 and a beta of 0.81. The company has a debt-to-equity ratio of 0.49, a current ratio of 3.06 and a quick ratio of 2.34. The company's fifty day moving average price is $217.13 and its 200 day moving average price is $216.52. STERIS plc has a 1-year low of $195.47 and a 1-year high of $254.00.

STERIS (NYSE:STE - Get Free Report) last posted its quarterly earnings data on Wednesday, May 8th. The medical equipment provider reported $2.58 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.41 by $0.17. The business had revenue of $1.42 billion during the quarter, compared to the consensus estimate of $1.41 billion. STERIS had a net margin of 6.95% and a return on equity of 13.73%. STERIS's quarterly revenue was up 10.8% compared to the same quarter last year. During the same period in the prior year, the firm earned $2.30 EPS. Equities analysts predict that STERIS plc will post 9.12 earnings per share for the current fiscal year.

STERIS Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 26th. Stockholders of record on Wednesday, June 12th will be paid a $0.52 dividend. The ex-dividend date of this dividend is Wednesday, June 12th. This represents a $2.08 dividend on an annualized basis and a dividend yield of 0.88%. STERIS's payout ratio is presently 54.45%.

Hedge Funds Weigh In On STERIS

Several large investors have recently made changes to their positions in the business. Mirae Asset Global Investments Co. Ltd. boosted its holdings in STERIS by 3.0% in the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 20,873 shares of the medical equipment provider's stock valued at $4,580,000 after purchasing an additional 614 shares during the period. TD Asset Management Inc increased its position in shares of STERIS by 7.2% during the third quarter. TD Asset Management Inc now owns 50,612 shares of the medical equipment provider's stock valued at $11,105,000 after purchasing an additional 3,401 shares during the period. Fifth Third Bancorp raised its stake in shares of STERIS by 9.7% in the third quarter. Fifth Third Bancorp now owns 3,041 shares of the medical equipment provider's stock valued at $667,000 after purchasing an additional 268 shares in the last quarter. Jennison Associates LLC boosted its stake in STERIS by 10.0% during the third quarter. Jennison Associates LLC now owns 167,295 shares of the medical equipment provider's stock worth $36,708,000 after buying an additional 15,204 shares in the last quarter. Finally, Teacher Retirement System of Texas boosted its stake in STERIS by 1.8% during the third quarter. Teacher Retirement System of Texas now owns 7,647 shares of the medical equipment provider's stock worth $1,678,000 after buying an additional 138 shares in the last quarter. Institutional investors and hedge funds own 94.69% of the company's stock.

Analyst Ratings Changes

A number of analysts have recently issued reports on STE shares. Piper Sandler reissued a "neutral" rating and issued a $225.00 price target (up from $220.00) on shares of STERIS in a research report on Friday, May 10th. KeyCorp assumed coverage on shares of STERIS in a research note on Tuesday, February 6th. They issued an "overweight" rating and a $253.00 price target on the stock. StockNews.com raised STERIS from a "hold" rating to a "buy" rating in a research report on Saturday. Needham & Company LLC reiterated a "hold" rating on shares of STERIS in a report on Friday, May 10th. Finally, Stephens reiterated an "overweight" rating and issued a $250.00 target price on shares of STERIS in a research note on Friday, February 9th. Three research analysts have rated the stock with a hold rating and four have given a buy rating to the company's stock. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average price target of $241.60.

About STERIS

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.